510(k) Report

FDA applicant

Trisalus Life Sciences

Westminster, CO4 decisions2019–20260 recalls

FDA records 4 decisions for Trisalus Life Sciences (Westminster, CO) from 2019 to 2026: 4 510(k) clearances. Most are in product codes KRA (Catheter, Continuous Flush) and DQY (Catheter, Percutaneous). Since 2016 its 510(k)s took a median of 27 days from receipt to decision, against 124 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Trisalus Life Sciences’s devices, and how often a recall has named them.

FDA decisions per year

2in 2023

2019: 12023: 22026 (partial year): 1
2019high 2 (2023) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2019.

FIG. 1 — Trisalus Life Sciences by year, 2019–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Trisalus Life Sciences’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report